Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Q1 PREVIEW: Things can only get better for Intuitive

This article was originally published in Clinica

Executive Summary

Intuitive Surgical’s first quarter results, due out on 21 April, could be an improvement over last year, analysts believe. They are predicting sales of $535.7m, representing 15% year-on-year growth; but perhaps more importantly, analysts are expecting adjusted earnings to grow to $3.87 per share, from $3.54 in Q1 2014.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT102536

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel